99 related articles for article (PubMed ID: 16014854)
21. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
Ndounga M; Tahar R; Basco LK; Casimiro PN; Malonga DA; Ntoumi F
Trop Med Int Health; 2007 Oct; 12(10):1164-71. PubMed ID: 17956498
[TBL] [Abstract][Full Text] [Related]
22. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
23. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
24. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
[TBL] [Abstract][Full Text] [Related]
25. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor.
Burns M; Baker J; Auliff AM; Gatton ML; Edstein MD; Cheng Q
Am J Trop Med Hyg; 2006 Mar; 74(3):361-6. PubMed ID: 16525092
[TBL] [Abstract][Full Text] [Related]
27. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
29. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
[TBL] [Abstract][Full Text] [Related]
30. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
[TBL] [Abstract][Full Text] [Related]
31. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
32. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
33. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
[TBL] [Abstract][Full Text] [Related]
34. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
[TBL] [Abstract][Full Text] [Related]
35. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
Takahashi T; Kanda T; Iwamoto A
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
37. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Bolaji OM; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Am J Trop Med Hyg; 2006 Jul; 75(1):155-61. PubMed ID: 16837724
[TBL] [Abstract][Full Text] [Related]
38. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Nkhoma S; Molyneux M; Ward S
Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
[TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology of malaria in Cameroon. XXII. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles.
Tahar R; Basco LK
Am J Trop Med Hyg; 2006 Sep; 75(3):396-401. PubMed ID: 16968912
[TBL] [Abstract][Full Text] [Related]
40. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]